Search Results - "WEINKNECHT, S"

Residual Tumor Resection After High-Dose Chemotherapy in Patients With Relapsed or Refractory Germ Cell Cancer by RICK, O, BOKEMEYER, C, SIEGERT, W, BEYER, J, WEINKNECHT, S, SCHIRREN, J, POTTEK, T, HARTMANN, J. T, BRAUN, T, RACHUD, B, WEISSBACH, L, HARTMANN, M

“…To assess the role of residual tumor resection performed after high-dose chemotherapy (HDCT) in patients with relapsed or refractory germ cell tumors (GCT)…”
Get full text

Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium: A phase II clinical trial by von der Maase, H., Andersen, L., Crinò, L., Weinknecht, S., Dogliotti, L.

“…Purpose: To determine the efficacy of gemcitabine and cisplatin combination therapy in patients with advanced and/or meta-static transitional cell urothelial…”
Get full text

Single agent carboplatin for CS IIA/B testicular seminoma. A phase II study of the German Testicular Cancer Study Group (GTCSG) by Krege, S., Boergermann, C., Baschek, R., Hinke, A., Pottek, T., Kliesch, S., Dieckmann, K.-P., Albers, P., Knutzen, B., Weinknecht, S., Schmoll, H.-J., Beyer, J., Ruebben, H.

“…Background: The aim was to investigate the use of single agent carboplatin in patients with seminoma stage IIA/B. Patients and methods: In a prospective phase…”
Get full text

Ureteroarterial fistula - pathogenesis, diagnostics, and therapeutic outcome by Luther, B, von Lilien-Waldau, V, Mamopoulos, A, Katoh, M, Friedrich, M, Weinknecht, S, Lent, V

“…Although ureteroarterial fistulas are rare, they result in a high mortality because of the massive urogenital haemorrhage. The diagnosis is often difficult…”
Get more information

Marked increase of the growth factors pleiotrophin and fibroblast growth factor-2 in serum of testicular cancer patients by Aigner, A., Brachmann, P., Beyer, J., Jäger, R., Raulais, D., Vigny, M., Neubauer, A., Heidenreich, A., Weinknecht, S., Czubayko, F., Zugmaier, G.

“…Background: Malignant tumors of the testis are among the most common cancers in men between the ages of 15 and 30 years. The sensitivity of detection of known…”
Get full text

Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors : incidence and implications for hematologic recovery and clinical outcome by BEYER, J, RICK, O, WEINKNECHT, S, KINGREEN, D, LENZ, K, SIEGERT, W

“…High-dose carboplatin, etoposide and ifosfamide (CEI) is an active chemotherapy regimen (HDCT) in solid tumors and lymphomas. In patients with previous…”
Get full text

A phase II trial of pemetrexed in patients with metastatic renal cancer by THÖDTMANN, R, SAUTER, T, WEINKNECHT, S, WEISSBACH, L, BLATTER, J, OHNMACHT, U, HANAUSKE, A.-R

“…Metastatic renal cell carcinoma (RCC) is rising in incidence but remains difficult to treat. This clinical trial evaluated the effects of pemetrexed…”
Get full text

Comparison of German Language Versions of the QWB-SA and SF-36 Evaluating Outcomes for Patients with Prostate Disease by D. Frosch, Porzsolt, F., R. Heicappell, K. Kleinschmidt, M. Schatz, S. Weinknecht, Kaplan, R. M.

“…Background: The quality of well-being scale (QWB) and the Medical Outcome Study 36-item short form (SF-36) are alternative methods for measuring general health…”
Get full text

European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG) by Schmoll, H. J., Souchon, R., Krege, S., Albers, P., Beyer, J., Kollmannsberger, C., Fossa, S. D., Skakkebaek, N. E., de Wit, R., Fizazi, K., Droz, J. P., Pizzocaro, G., Daugaard, G., de Mulder, P. H. M., Horwich, A., Oliver, T., Huddart, R., Rosti, G., Paz Ares, L., Pont, O., Hartmann, J. T., Aass, N., Algaba, F., Bamberg, M., Bodrogi, I., Bokemeyer, C., Classen, J., Clemm, S., Culine, S., de Wit, M., Derigs, H. G., Dieckmann, K. P., Flasshove, M., Garcia del Muro, X., Gerl, A., Germa-Lluch, J. R., Hartmann, M., Heidenreich, A., Hoeltl, W., Joffe, J., Jones, W., Kaiser, G., Klepp, O., Kliesch, S., Kisbenedek, L., Koehrmann, K. U., Kuczyk, M., Laguna, M. P., Leiva, O., Loy, V., Mason, M. D., Mead, G. M., Mueller, R. P., Nicolai, N., Oosterhof, G. O. N., Pottek, T., Rick, O., Schmidberger, H., Sedlmayer, F., Siegert, W., Studer, U., Tjulandin, S., von der Maase, H., Walz, P., Weinknecht, S., Weissbach, L., Winter, E., Wittekind, C.

“…Germ cell tumour is the most frequent malignant tumour type in young men with a 100% rise in the incidence every 20 years. Despite this, the high sensitivity…”
Get full text

Radical cystectomy in patients aged ≥ 75 years: an updated review of patients treated with curative and palliative intent by Zebic, Nikola, Weinknecht, Stephan, Kroepfl, Darko

“…OBJECTIVE To evaluate the morbidity and mortality of radical cystectomy in a group of unselected patients aged ≥ 75 years who were treated with curative and…”
Get full text

Radiotherapy for Stages IIA/B Testicular Seminoma: Final Report of a Prospective Multicenter Clinical Trial by Classen, Johannes, Schmidberger, Heinz, Meisner, Christoph, Souchon, Rainer, Sautter-Bihl, Marie-Luise, Sauer, Rolf, Weinknecht, Stefan, Köhrmann, Kai-U, Bamberg, Michael

“…A prospective multicenter trial was initiated to evaluate the role of modern radiotherapy with reduced treatment portals for stage IIA and IIB testicular…”
Get full text

Marker-positive patients with germ-cell tumors: when is residual tumor resection useful? by Weinknecht, S., Hartmann, M., Weißbach, L.

“…We analyzed 33 patients with disseminated germ cell tumors (GCT) who underwent residual tumor resection (RTR) during the period from 1991-1997. The patients…”
Get full text

Radiotherapy for stages I and IIA/B testicular seminoma by Bamberg, Michael, Schmidberger, Heinz, Meisner, Christoph, Classen, Johannes, Souchon, Rainer, Weinknecht, Stefan, Schorcht, Johannes, Walter, Frank, Engenhart‐Cabillic, Rita, Schulz, Ulrich, Born, Holger, Flink, Maria

“…Radiotherapy is generally accepted as a standard treatment for early‐stage testicular seminoma. Relapse rates of 2% to 5% in clinical stage I and 10% to 20% in…”
Get full text

Single agent carboplatin or radiotherapy as adjuvant in stage I seminoma — Results of a prospective trial by Wiegel, T., Sautter, S., Winter, C., Weinknecht, S., Hinkelbein, W.

Get full text

Risk factors for relapse in stage I non‐seminomatous germ‐cell tumors: Preliminary results of the German multicenter trial by Albers, Peter, Siener, Roswitha, Hartmann, Michael, Weinknecht, Stefan, Schulze, Harald, Rebmann, Udo, Kuczyk, Markus, deRiese, Werner, Loy, Volker, Bierhoff, Erhard, Wittekind, Christian

“…Risk factor analysis to identify low‐risk patients for occult metastatic disease (vascular invasion, percentage embryonal carcinoma, MIB‐I proliferation rate)…”
Get full text

Risk factors for relapse in stage I non-seminomatous germ-cell tumors: preliminary results of the German Multicenter Trial. German Testicular Cancer Study Group by Albers, P, Siener, R, Hartmann, M, Weinknecht, S, Schulze, H, Rebmann, U, Kuczyk, M, deRiese, W, Loy, V, Bierhoff, E, Wittekind, C

“…Risk factor analysis to identify low-risk patients for occult metastatic disease (vascular invasion, percentage embryonal carcinoma, MIB-I proliferation rate)…”
Get full text

501Radiotherapy or single agent carboplatin as adjuvant in stage I seminoma — preliminary results by Wiegel, T., Steiner, U., Weinknecht, S., Diekmann, K.P., Hinkelbein, W.

Get full text

Risk factors for relapse in stage I non-seminomatous germ-cell tumors : Preliminary results of the German multicenter trial : Special Section : UICC Symposium on Testicular Cancer by ALBERS, P, SIENER, R, WITTEKIND, C, HARTMANN, M, WEINKNECHT, S, SCHULZE, H, REBMANN, U, KUCZYK, M, DERIESE, W, LOY, V, BIERHOFF, E

Get full text

Radiotherapy for stages I and IIA/B testicular seminoma : Special Section : UICC Symposium on Testicular Cancer by BAMBERG, M, SCHMIDBERGER, H, BORN, H, FLINK, M, MEISNER, C, CLASSEN, J, SOUCHON, R, WEINKNECHT, S, SCHORCHT, J, WALTER, F, ENGENHART-CABILLIC, R, SCHULZ, U

Get full text

Interdisciplinary consensus on diagnosis and therapy of testicular tumors. Results of an update conference based on evidence-based medicine. German Testicular Cancer study Group (GTCSG) by Souchon, R, Krege, S, Schmoll, H J, Albers, P, Beyer, J, Bokemeyer, C, Classen, J, Dieckmann, K P, Hartmann, M, Heidenreich, A, Höltl, W, Kliesch, S, Köhrmann, K U, Kuczyk, M, Schmidberger, H, Weinknecht, S, Winter, E, Wittekind, C, Bamberg, M

“…An "Interdisciplinary Consensus Statement on the Diagnosis and Therapy of Testicular Tumors" was prepared in 1996 by the "Interdisciplinary Testicular Tumor…”
Get full text